Literature DB >> 26856795

Blood Pressure Control Provides Less Cardiovascular Protection in Adults With Than Without Apparent Treatment-Resistant Hypertension.

Brent M Egan1,2, Bo Kai3, C Shaun Wagner2, Joseph H Henderson1, Archie H Chandler1, Angelo Sinopoli1,2.   

Abstract

Hypertension control may offer less protection from incident cardiovascular disease (CVDi ) in adults with than without apparent treatment-resistant hypertension (aTRH), ie, blood pressure uncontrolled while taking three or more antihypertensive medications or controlled to <140/<90 mm Hg while taking four or more antihypertensive medications. Electronic health data were matched to health claims for 2006-2012. Patients with CVDi in 2006-2007 or with untreated hypertension were excluded, leaving 118,356 treated hypertensives, including 40,690 with aTRH, and 460,599 observation years. Blood pressure and medication number were determined by all clinic visit means from 2008 to CVDi or end of study. Primary outcome was first CVDi (stroke, coronary heart disease, heart failure) from hospital and emergency department claims. Controlling for age, race, sex, diabetes, chronic kidney disease, and statin use, hypertension control afforded less CVDi protection in patients with aTRH (hazard ratio, 0.87; 95% confidence interval, 0.82-0.93) than without aTRH (hazard ratio, 0.69; 95% confidence interval, 0.65-0.74; P<.001). Strategies beyond hypertension control may prevent more CVDi in patients with aTRH.
© 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26856795      PMCID: PMC5837039          DOI: 10.1111/jch.12773

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  37 in total

1.  Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement.

Authors:  John M Flack; Domenic A Sica; George Bakris; Angela L Brown; Keith C Ferdinand; Richard H Grimm; W Dallas Hall; Wendell E Jones; David S Kountz; Janice P Lea; Samar Nasser; Shawna D Nesbitt; Elijah Saunders; Margaret Scisney-Matlock; Kenneth A Jamerson
Journal:  Hypertension       Date:  2010-10-04       Impact factor: 10.190

2.  Incidence and prognosis of resistant hypertension in hypertensive patients.

Authors:  Stacie L Daugherty; J David Powers; David J Magid; Heather M Tavel; Frederick A Masoudi; Karen L Margolis; Patrick J O'Connor; Joe V Selby; P Michael Ho
Journal:  Circulation       Date:  2012-02-29       Impact factor: 29.690

3.  US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.

Authors:  Brent M Egan; Yumin Zhao; R Neal Axon
Journal:  JAMA       Date:  2010-05-26       Impact factor: 56.272

4.  Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.

Authors:  Marguerite R Irvin; John N Booth; Daichi Shimbo; Daniel T Lackland; Suzanne Oparil; George Howard; Monika M Safford; Paul Muntner; David A Calhoun
Journal:  J Am Soc Hypertens       Date:  2014-03-15

5.  Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension.

Authors:  Sante D Pierdomenico; Domenico Lapenna; Anna Bucci; Roberta Di Tommaso; Rocco Di Mascio; Bianca M Manente; Maria P Caldarella; Matteo Neri; Franco Cuccurullo; Andrea Mezzetti
Journal:  Am J Hypertens       Date:  2005-11       Impact factor: 2.689

6.  Systolic blood pressure and cardiovascular outcomes during treatment of hypertension.

Authors:  Michael A Weber; George L Bakris; Allen Hester; Matthew R Weir; Tsushung A Hua; Dion Zappe; Bjorn Dahlof; Eric J Velazquez; Bertram Pitt; Kenneth Jamerson
Journal:  Am J Med       Date:  2013-03-28       Impact factor: 4.965

7.  Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008.

Authors:  Brent M Egan; Yumin Zhao; R Neal Axon; Walter A Brzezinski; Keith C Ferdinand
Journal:  Circulation       Date:  2011-08-08       Impact factor: 29.690

8.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

9.  Trends in dietary quality among adults in the United States, 1999 through 2010.

Authors:  Dong D Wang; Cindy W Leung; Yanping Li; Eric L Ding; Stephanie E Chiuve; Frank B Hu; Walter C Willett
Journal:  JAMA Intern Med       Date:  2014-10       Impact factor: 21.873

10.  Different definitions of prevalent hypertension impact: the clinical epidemiology of hypertension and attainment of Healthy People goals.

Authors:  Brent M Egan; Yumin Zhao
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-12-26       Impact factor: 3.738

View more
  8 in total

Review 1.  Nonpharmacological Management of Resistant Hypertension.

Authors:  Ahmad Sabbahi; Richard Severin; Deepika Laddu; James E Sharman; Ross Arena; Cemal Ozemek
Journal:  Curr Cardiol Rep       Date:  2021-10-01       Impact factor: 3.955

2.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

Review 3.  Treatment of Resistant and Refractory Hypertension.

Authors:  Maria Czarina Acelajado; Zachary H Hughes; Suzanne Oparil; David A Calhoun
Journal:  Circ Res       Date:  2019-03-29       Impact factor: 17.367

4.  Blood Pressure Control Provides Less Cardiovascular Protection in Adults With Than Without Apparent Treatment-Resistant Hypertension.

Authors:  Brent M Egan; Bo Kai; C Shaun Wagner; Joseph H Henderson; Archie H Chandler; Angelo Sinopoli
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-02-09       Impact factor: 3.738

5.  Low Blood Pressure Is Associated With Greater Risk for Cardiovascular Events in Treated Adults With and Without Apparent Treatment-Resistant Hypertension.

Authors:  Brent M Egan; Bo Kai; C Shaun Wagner; Douglas O Fleming; Joseph H Henderson; Archie H Chandler; Angelo Sinopoli
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-10-21       Impact factor: 3.738

6.  Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus.

Authors:  Francesca Viazzi; Pamela Piscitelli; Antonio Ceriello; Paola Fioretto; Carlo Giorda; Pietro Guida; Giuseppina Russo; Salvatore De Cosmo; Roberto Pontremoli
Journal:  J Am Heart Assoc       Date:  2017-09-22       Impact factor: 5.501

7.  Optimal Systolic Blood Pressure Target in Resistant and Non-Resistant Hypertension: A Pooled Analysis of Patient-Level Data from SPRINT and ACCORD.

Authors:  Steven M Smith; Matthew J Gurka; David A Calhoun; Yan Gong; Carl J Pepine; Rhonda M Cooper-DeHoff
Journal:  Am J Med       Date:  2018-08-22       Impact factor: 4.965

8.  Prevalence and prognosis of the 2018 vs 2008 AHA definitions of apparent treatment-resistant hypertension in high-risk hypertension patients.

Authors:  Kyeong-Hyeon Chun; Chan Joo Lee; Jaewon Oh; Sang-Hak Lee; Seok-Min Kang; Kazuomi Kario; Sungha Park
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-20       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.